Preoperative bilirubin normalization and outcomes after pancreaticoduodenectomy in patients with predominantly mild-to-moderate obstructive jaundice due to periampullary tumors

Year 2026, Volume: 9 Issue: 2, 530 - 536, 12.03.2026

Yusuf Yunus Korkmaz , İlyas Kudaş , Feyyaz Güngör , Oğuzhan Aydın , Murat Altay , Özgür Bostancı , Erdem Kınacı

https://izlik.org/JA55NT72NM

Abstract

Aims: Pancreaticoduodenectomy remains the cornerstone of curative treatment for periampullary tumors but is associated with substantial postoperative morbidity. Obstructive jaundice is common in this setting and has traditionally been regarded as a risk factor warranting delay of surgery until biochemical normalization of bilirubin. However, evidence supporting this strategy remains conflicting, particularly in patients with mild to moderate hyperbilirubinemia.
Methods: This retrospective single-center cohort study screened 295 consecutive patients who underwent pancreaticoduodenectomy for suspected periampullary tumors between June 2020 and August 2025. To specifically evaluate the impact of cholestasis, patients without preoperative hyperbilirubinemia were excluded. The final study cohort comprised 197 patients with cholestasis-associated periampullary tumors, including patients operated on with elevated bilirubin levels and those who underwent preoperative biliary drainage due to bilirubin elevation. Preoperative total bilirubin, C-reactive protein (CRP), and white blood cell count were recorded within 72 hours prior to surgery. Postoperative morbidity was assessed using the Clavien–Dindo classification, with overall morbidity defined as Clavien–Dindo grade ≥1 and major morbidity as Clavien Dindo grade ≥3. Bilirubin was evaluated both as a continuous variable and using clinically relevant cut-off values. Multivariable analyses were performed to identify independent associations with postoperative outcomes.
Results: The mean preoperative total bilirubin level was 3.01±2.91 mg/dl. Preoperative bilirubin levels were not independently associated with overall morbidity, major morbidity, or postoperative mortality across multiple thresholds (≥2 mg/dl, >5 mg/dl, and >10 mg/dl). Similarly, the combined elevation of bilirubin and CRP did not predict increased postoperative morbidity or mortality. However, a more selective inflammatory cholestasis phenotype (bilirubin >5 mg/dl and CRP ≥10 mg/L) was independently associated with prolonged hospital stay after adjustment for age and American Society of Anesthesiologists (ASA) physical status.
Conclusion: In this cohort of patients with cholestasis-associated periampullary tumors, preoperative hyperbilirubinemia—alone or combined with inflammatory markers—was not associated with increased postoperative morbidity or mortality after pancreaticoduodenectomy. These findings suggest that, in clinically stable patients with mild to moderate obstructive jaundice, delaying surgery solely to achieve biochemical normalization of bilirubin may not be necessary. Preoperative cholestasis and inflammation may be more informative for anticipating postoperative recovery patterns than for determining surgical eligibility.

Keywords

Pancreaticoduodenectomy , periampullary tumors , hyperbilirubinemia , obstructive jaundice , preoperative biliary drainage , postoperative morbidity , inflammatory markers

Ethical Statement

This study was approved by the Istanbul Başakşehir Çam and Sakura City Hospital Ethics Committee (Date: 17.12.2025, Decision No: 444). Because the study was designed retrospectively, no written informed consent was obtained from the patients.

Supporting Institution

This study did not receive any financial or institutional support.

Project Number

Not applicable

Thanks

Not applicable

References

• Aizpuru M, Starlinger P, Nagorney DM, Smoot RL, Truty MJ, Kendrick ML. Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesions. HPB (Oxford). 2022;24(9):1416. doi:10. 1016/j.hpb.2022.01.007
• Zhang B, Lang Z, Zhu K, Luo W, Zhao Z, Zhang Z. Whether preoperative biliary drainage leads to better patient outcomes of pancreaticoduodenectomy: a meta-analysis and systematic review. BMC Gastroenterol. 2025;25(1):161. doi:10.1186/s12876-025-03761-x
• Liu J, Sun Y, Xu Y, Mei HW, Wu G, Li Z. Pathophysiological consequences and treatment strategy of obstructive jaundice. World J Gastrointest Surg. 2023;15(7):1262. doi:10.4240/wjgs.v15.i7.1262
• Zhu L, Yang Y, Cheng H, Cai Z, Tang N, Mao L. The role of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy in patients with obstructive jaundice. Gland Surg. 2023;12(5):593. doi:10.21037/gs-22-648
• Yu Z, Du MM, Zhang X, Suo J, Zeng T, Xie XL. The impact of preoperative biliary drainage on postoperative healthcare-associated infections and clinical outcomes following pancreaticoduodenectomy: a ten-year retrospective analysis. BMC Infect Dis. 2024;24(1):361. doi:10. 1186/s12879-024-09246-8
• Moldovan S, Moiş E, Graur F, Puia IC, Vlad I, Nechita VI. A systematic review and meta-analysis of preoperative biliary drainage methods in periampullary tumors. J Clin Med. 2025;14(19):7097. doi:10.3390/jcm 14197097
• Tai D, Conroy T, Lee JJX, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer. ESMO Open. 2025;10(10):105826. doi:10.1016/j.esmoop.2025.105826
• Kanani F, Messer N, Cohen B, Falk E, Goykhman Y, Lubezky N. Impact of preoperative biliary drainage on outcomes of pancreaticoduodenectomy in severe hyperbilirubinemia. Surg Endosc. 2025;39(10):6504. doi:10.1007/s00464-025-12027-2
• Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987. doi:10.1016/j.annonc.2023.08.009
• Li Y, Pu S, Zong K, et al. Impact of serum bilirubin levels and preoperative biliary drainage on perioperative complications of pancreaticoduodenectomy. Front Med (Lausanne). 2025;12:1535106. doi:10.3389/fmed.2025.1535106
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg. 2004;240(2):205-213. doi:10.1097/01.sla. 0000133083.54934.ae
• Fang Y, Gurusamy KS, Wang Q, et al. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012;(9):CD005444. doi:10.1002/14651858.cd005444.pub3
• Guo Q, Wan J, Huang Y, et al. Management of preoperative biliary drainage on postoperative complications and mortality in patients with different degrees of obstructive jaundice undergoing pancreaticoduodenectomy. Ann Hepatobiliary Pancreat Surg. 2025; 29(4):405. doi:10.14701/ahbps.25-123
• Pastena MD, Marchegiani G, Paiella S, et al. Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: an analysis of 1500 consecutive cases. Dig Endosc. 2018;30(6):777-784. doi: 10.1111/den.13221
• van der Gaag NA, Rauws EA, van Eijck CHJ, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010; 362(2):129-137. doi:10.1056/NEJMoa0903230
• Chen Y, Ou G, Lian G, Luo H, Huang K, Huang Y. Effect of preoperative biliary drainage on complications following pancreatoduodenectomy. Medicine (Baltimore). 2015;94(29):e1199. doi:10.1097/MD.0000000000001199
• Gong S, Song S, Cheng Q, et al. Efficacy and safety of preoperative biliary drainage in patients undergoing pancreaticoduodenectomy: an updated systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15(12):1411-1426. doi:10.1080/17474124.2021.2013805
• Scherber PR, Gäbelein G, Spiliotis AE, et al. Role of biliary drainage before pancreatoduodenectomy for pancreatic adenocarcinoma: a retrospective study. Minerva Surg. 2022;77(6):550-557. doi:10.23736/S2724-5691.22.09414-X
• Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31-40. doi:10.1002/jhbp.509
• Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int. 2018;17(1):17-21. doi:10.1016/j.hbpd.2018.01.008
• Dolejs SC, Zarzaur BL, Zyromski NJ, et al. Does hyperbilirubinemia contribute to adverse patient outcomes following pancreatoduodenectomy? J Gastrointest Surg. 2017;21(4):647-656. doi: 10.1007/s11605-017-3381-6
• Parapini M, Skipworth J, Mah A, et al. The association between bacterobilia and the risk of postoperative complications following pancreaticoduodenectomy. HPB (Oxford). 2021;24(2):277. doi:10.1016/j.hpb.2021.06.428
• Mintziras I, Maurer E, Kanngießer V, Lohoff M, Bartsch DK. Preoperative bacterobilia is an independent risk factor of SSIs after partial PD. Dig Surg. 2020;37(5):428-436. doi:10.1159/000508127
• Müssle B, Hempel S, Kahlert C, et al. Prognostic impact of bacterobilia on morbidity and postoperative management after pancreatoduodenectomy: a systematic review and meta-analysis. World J Surg. 2018;42(9):2951-2960. doi:10.1007/s00268-018-4546-5
• Groen JV, Droogh D, de Boer M, et al. Clinical implications of bile cultures obtained during pancreatoduodenectomy: a cohort study and meta-analysis. HPB (Oxford). 2020;23(7):1123-1133. doi:10.1016/j.hpb. 2020.10.028
• Pretzsch E, Heim A, Heiliger C, et al. Specific intraoperative antibiotic therapy abrogates the negative effect of biliary contamination on the comprehensive complication index after pancreatic head resection. Surgery. 2021;171(6):1642-1651. doi:10.1016/j.surg.2021.10.022
• Droogh D, Groen JV, de Boer M, et al. Prolonged antibiotic prophylaxis after pancreatoduodenectomy: systematic review and meta-analysis. Br J Surg. 2023;110(11):1458-1466. doi:10.1093/bjs/znad213
• Ahmed M. Acute cholangitis—an update. World J Gastrointest Pathophysiol. 2018;9(1):1. doi:10.4291/wjgp.v9.i1.1
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812. doi:10.1172/JCI18921
• Rashid Z, Munir MM, Woldesenbet S, et al. Association of preoperative cholangitis with outcomes and expenditures among patients undergoing pancreaticoduodenectomy. J Gastrointest Surg. 2024;28(7):1137. doi:10. 1016/j.gassur.2024.05.009
• Frountzas M, Liatsou E, Schizas D, et al. The impact of surgery delay on survival of resectable pancreatic cancer: a systematic review of observational studies. Surg Oncol. 2022;45:101855. doi:10.1016/j.suronc. 2022.101855
• Pisani RPL, Archibugi T, Lazzano P, et al. Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Dig Liver Dis. 2025;57(6):1308-1314. doi:10.1016/j.dld.2025.03.009
• Eshuis WJ, van der Gaag NA, Rauws EA, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg. 2010;252(5):840-849. doi:10.1097/SLA.0b013e3181fd36a2
• Bineshfar N, Alamdari NM, Rostami T, et al. The effect of preoperative biliary drainage on postoperative complications of pancreaticoduodenectomy: a triple center retrospective study. BMC Surg. 2022;22(1):399. doi:10.1186/s12893-022-01853-z
• Satoh D, Hiroyoshi M, Shiozaki S. The optimal type and management of biliary drainage in patients with obstructive jaundice who undergo pancreaticoduodenectomy. In Vivo. 2021;36(1):391. doi:10.21873/invivo. 12716
• Li Y, Yang T. Effect of preoperative biliary drainage in resectable periampullary lesions: systematic review and meta-analysis. Cir Cir. 2024;92(3):338. doi:10.24875/CIRU.23000318